Loading…
Eldecalcitol Induces Minimodeling-Based Bone Formation and Inhibits Sclerostin Synthesis Preferentially in the Epiphyses Rather than the Metaphyses of the Long Bones in Rats
This study aimed to examine minimodeling-based bone formation between the epiphyses and metaphyses of the long bones of eldecalcitol (ELD)-administered ovariectomized rats. Sixteen-week-old female rats were divided into four groups: sham-operated rats receiving vehicle (Sham group), ovariectomized (...
Saved in:
Published in: | International journal of molecular sciences 2024-04, Vol.25 (8), p.4257 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c381t-a53bb9bb5425a5f8ca5f88e0f80973085af1e23bdcbe246e95c6c0d7b6bdfc853 |
container_end_page | |
container_issue | 8 |
container_start_page | 4257 |
container_title | International journal of molecular sciences |
container_volume | 25 |
creator | Hasegawa, Tomoka Yamamoto, Tomomaya Hongo, Hiromi Yamamoto, Tsuneyuki Haraguchi-Kitakamae, Mai Ishizu, Hotaka Shimizu, Tomohiro Saito, Hitoshi Sakai, Sadaoki Yogo, Kenji Matsumoto, Yoshihiro Amizuka, Norio |
description | This study aimed to examine minimodeling-based bone formation between the epiphyses and metaphyses of the long bones of eldecalcitol (ELD)-administered ovariectomized rats. Sixteen-week-old female rats were divided into four groups: sham-operated rats receiving vehicle (Sham group), ovariectomized (OVX) rats receiving vehicle (Vehicle group), or ELDs (30 or 90 ng/kg BW, respectively; ELD30 and ELD90 groups). ELD administration increased bone volume and trabecular thickness, reducing the number of osteoclasts in both the epiphyses and metaphyses of OVX rats. The Sham and Vehicle groups exhibited mainly remodeling-based bone formation in both regions. The epiphyses of the ELD groups showed a significantly higher frequency of minimodeling-based bone formation than remodeling-based bone formation. In contrast, the metaphyses exhibited significantly more minimodeling-based bone formation in the ELD90 group compared with the ELD30 group. However, there was no significant difference between minimodeling-based bone formation and remodeling-based bone formation in the ELD90 group. While the minimodeling-induced new bone contained few sclerostin-immunoreactive osteocytes, the underlying pre-existing bone harbored many. The percentage of sclerostin-positive osteocytes was significantly reduced in the minimodeling-induced bone in the epiphyses but not in the metaphyses of the ELD groups. Thus, it seems likely that ELD could induce minimodeling-based bone formation in the epiphyses rather than in the metaphyses, and that ELD-driven minimodeling may be associated with the inhibition of sclerostin synthesis. |
doi_str_mv | 10.3390/ijms25084257 |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_3047949574</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A793549854</galeid><sourcerecordid>A793549854</sourcerecordid><originalsourceid>FETCH-LOGICAL-c381t-a53bb9bb5425a5f8ca5f88e0f80973085af1e23bdcbe246e95c6c0d7b6bdfc853</originalsourceid><addsrcrecordid>eNptkk1v1DAQhiMEoqVw44wsceHQFCeOE_vYVluotBWIwjnyx2TXK8debOewP4r_WKe7VFuELPlj3mdmrFdTFO8rfEEIx5_NZow1xaypafeiOK2aui4xbruXR_eT4k2MG4xrUlP-ujghrO0Ia5rT4s_CalDCKpO8RbdOTwoiujPOjF6DNW5VXokIGl15B-jGh1Ek4x0STmd6baRJEd0rC8HHZBy637m0hmgi-h5ggAAuGWHtDmUtC2ixNdv1LuYeP0R-hxwUe-UOkjhIfniMLL1bPfaNc3bm49vi1SBshHeH86z4dbP4ef21XH77cnt9uSwVYVUqBSVScilp9kTQgal5Y4AHhnlHMKNiqKAmUisJddMCp6pVWHeylXpQjJKz4tO-7jb43xPE1I8mKrBWOPBT7AluOt5w2jUZ_fgPuvFTcPl3M9XyCpP2iFoJC71xg09BqLlof9lxQhvO6Exd_IfKS8NoVDZiMDn-LOF8n6Cy_TEb3m-DGUXY9RXu5-noj6cj4x8Of53kCPoJ_jsO5AFNcLdn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3046910364</pqid></control><display><type>article</type><title>Eldecalcitol Induces Minimodeling-Based Bone Formation and Inhibits Sclerostin Synthesis Preferentially in the Epiphyses Rather than the Metaphyses of the Long Bones in Rats</title><source>PubMed (Medline)</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><creator>Hasegawa, Tomoka ; Yamamoto, Tomomaya ; Hongo, Hiromi ; Yamamoto, Tsuneyuki ; Haraguchi-Kitakamae, Mai ; Ishizu, Hotaka ; Shimizu, Tomohiro ; Saito, Hitoshi ; Sakai, Sadaoki ; Yogo, Kenji ; Matsumoto, Yoshihiro ; Amizuka, Norio</creator><creatorcontrib>Hasegawa, Tomoka ; Yamamoto, Tomomaya ; Hongo, Hiromi ; Yamamoto, Tsuneyuki ; Haraguchi-Kitakamae, Mai ; Ishizu, Hotaka ; Shimizu, Tomohiro ; Saito, Hitoshi ; Sakai, Sadaoki ; Yogo, Kenji ; Matsumoto, Yoshihiro ; Amizuka, Norio</creatorcontrib><description>This study aimed to examine minimodeling-based bone formation between the epiphyses and metaphyses of the long bones of eldecalcitol (ELD)-administered ovariectomized rats. Sixteen-week-old female rats were divided into four groups: sham-operated rats receiving vehicle (Sham group), ovariectomized (OVX) rats receiving vehicle (Vehicle group), or ELDs (30 or 90 ng/kg BW, respectively; ELD30 and ELD90 groups). ELD administration increased bone volume and trabecular thickness, reducing the number of osteoclasts in both the epiphyses and metaphyses of OVX rats. The Sham and Vehicle groups exhibited mainly remodeling-based bone formation in both regions. The epiphyses of the ELD groups showed a significantly higher frequency of minimodeling-based bone formation than remodeling-based bone formation. In contrast, the metaphyses exhibited significantly more minimodeling-based bone formation in the ELD90 group compared with the ELD30 group. However, there was no significant difference between minimodeling-based bone formation and remodeling-based bone formation in the ELD90 group. While the minimodeling-induced new bone contained few sclerostin-immunoreactive osteocytes, the underlying pre-existing bone harbored many. The percentage of sclerostin-positive osteocytes was significantly reduced in the minimodeling-induced bone in the epiphyses but not in the metaphyses of the ELD groups. Thus, it seems likely that ELD could induce minimodeling-based bone formation in the epiphyses rather than in the metaphyses, and that ELD-driven minimodeling may be associated with the inhibition of sclerostin synthesis.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms25084257</identifier><identifier>PMID: 38673844</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adaptor Proteins, Signal Transducing - metabolism ; Animals ; Antibodies ; Bone and Bones - drug effects ; Bone and Bones - metabolism ; Bone Morphogenetic Proteins - metabolism ; Bone Remodeling - drug effects ; Bones ; Epiphyses - drug effects ; Epiphyses - metabolism ; Ethylenediaminetetraacetic acid ; Female ; Genetic Markers ; Instrument industry ; Osteoclasts - drug effects ; Osteoclasts - metabolism ; Osteogenesis - drug effects ; Osteoporosis ; Ovariectomy ; Pharmaceutical industry ; Rats ; Rats, Sprague-Dawley ; Tetracycline ; Tetracyclines ; Vitamin D - analogs & derivatives ; Vitamin D - pharmacology</subject><ispartof>International journal of molecular sciences, 2024-04, Vol.25 (8), p.4257</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c381t-a53bb9bb5425a5f8ca5f88e0f80973085af1e23bdcbe246e95c6c0d7b6bdfc853</cites><orcidid>0000-0003-0309-6637 ; 0000-0001-6760-3066 ; 0000-0001-5844-9343</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3046910364/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3046910364?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,25731,27901,27902,36989,36990,44566,75096</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38673844$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hasegawa, Tomoka</creatorcontrib><creatorcontrib>Yamamoto, Tomomaya</creatorcontrib><creatorcontrib>Hongo, Hiromi</creatorcontrib><creatorcontrib>Yamamoto, Tsuneyuki</creatorcontrib><creatorcontrib>Haraguchi-Kitakamae, Mai</creatorcontrib><creatorcontrib>Ishizu, Hotaka</creatorcontrib><creatorcontrib>Shimizu, Tomohiro</creatorcontrib><creatorcontrib>Saito, Hitoshi</creatorcontrib><creatorcontrib>Sakai, Sadaoki</creatorcontrib><creatorcontrib>Yogo, Kenji</creatorcontrib><creatorcontrib>Matsumoto, Yoshihiro</creatorcontrib><creatorcontrib>Amizuka, Norio</creatorcontrib><title>Eldecalcitol Induces Minimodeling-Based Bone Formation and Inhibits Sclerostin Synthesis Preferentially in the Epiphyses Rather than the Metaphyses of the Long Bones in Rats</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>This study aimed to examine minimodeling-based bone formation between the epiphyses and metaphyses of the long bones of eldecalcitol (ELD)-administered ovariectomized rats. Sixteen-week-old female rats were divided into four groups: sham-operated rats receiving vehicle (Sham group), ovariectomized (OVX) rats receiving vehicle (Vehicle group), or ELDs (30 or 90 ng/kg BW, respectively; ELD30 and ELD90 groups). ELD administration increased bone volume and trabecular thickness, reducing the number of osteoclasts in both the epiphyses and metaphyses of OVX rats. The Sham and Vehicle groups exhibited mainly remodeling-based bone formation in both regions. The epiphyses of the ELD groups showed a significantly higher frequency of minimodeling-based bone formation than remodeling-based bone formation. In contrast, the metaphyses exhibited significantly more minimodeling-based bone formation in the ELD90 group compared with the ELD30 group. However, there was no significant difference between minimodeling-based bone formation and remodeling-based bone formation in the ELD90 group. While the minimodeling-induced new bone contained few sclerostin-immunoreactive osteocytes, the underlying pre-existing bone harbored many. The percentage of sclerostin-positive osteocytes was significantly reduced in the minimodeling-induced bone in the epiphyses but not in the metaphyses of the ELD groups. Thus, it seems likely that ELD could induce minimodeling-based bone formation in the epiphyses rather than in the metaphyses, and that ELD-driven minimodeling may be associated with the inhibition of sclerostin synthesis.</description><subject>Adaptor Proteins, Signal Transducing - metabolism</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Bone and Bones - drug effects</subject><subject>Bone and Bones - metabolism</subject><subject>Bone Morphogenetic Proteins - metabolism</subject><subject>Bone Remodeling - drug effects</subject><subject>Bones</subject><subject>Epiphyses - drug effects</subject><subject>Epiphyses - metabolism</subject><subject>Ethylenediaminetetraacetic acid</subject><subject>Female</subject><subject>Genetic Markers</subject><subject>Instrument industry</subject><subject>Osteoclasts - drug effects</subject><subject>Osteoclasts - metabolism</subject><subject>Osteogenesis - drug effects</subject><subject>Osteoporosis</subject><subject>Ovariectomy</subject><subject>Pharmaceutical industry</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Tetracycline</subject><subject>Tetracyclines</subject><subject>Vitamin D - analogs & derivatives</subject><subject>Vitamin D - pharmacology</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkk1v1DAQhiMEoqVw44wsceHQFCeOE_vYVluotBWIwjnyx2TXK8debOewP4r_WKe7VFuELPlj3mdmrFdTFO8rfEEIx5_NZow1xaypafeiOK2aui4xbruXR_eT4k2MG4xrUlP-ujghrO0Ia5rT4s_CalDCKpO8RbdOTwoiujPOjF6DNW5VXokIGl15B-jGh1Ek4x0STmd6baRJEd0rC8HHZBy637m0hmgi-h5ggAAuGWHtDmUtC2ixNdv1LuYeP0R-hxwUe-UOkjhIfniMLL1bPfaNc3bm49vi1SBshHeH86z4dbP4ef21XH77cnt9uSwVYVUqBSVScilp9kTQgal5Y4AHhnlHMKNiqKAmUisJddMCp6pVWHeylXpQjJKz4tO-7jb43xPE1I8mKrBWOPBT7AluOt5w2jUZ_fgPuvFTcPl3M9XyCpP2iFoJC71xg09BqLlof9lxQhvO6Exd_IfKS8NoVDZiMDn-LOF8n6Cy_TEb3m-DGUXY9RXu5-noj6cj4x8Of53kCPoJ_jsO5AFNcLdn</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Hasegawa, Tomoka</creator><creator>Yamamoto, Tomomaya</creator><creator>Hongo, Hiromi</creator><creator>Yamamoto, Tsuneyuki</creator><creator>Haraguchi-Kitakamae, Mai</creator><creator>Ishizu, Hotaka</creator><creator>Shimizu, Tomohiro</creator><creator>Saito, Hitoshi</creator><creator>Sakai, Sadaoki</creator><creator>Yogo, Kenji</creator><creator>Matsumoto, Yoshihiro</creator><creator>Amizuka, Norio</creator><general>MDPI AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0309-6637</orcidid><orcidid>https://orcid.org/0000-0001-6760-3066</orcidid><orcidid>https://orcid.org/0000-0001-5844-9343</orcidid></search><sort><creationdate>20240401</creationdate><title>Eldecalcitol Induces Minimodeling-Based Bone Formation and Inhibits Sclerostin Synthesis Preferentially in the Epiphyses Rather than the Metaphyses of the Long Bones in Rats</title><author>Hasegawa, Tomoka ; Yamamoto, Tomomaya ; Hongo, Hiromi ; Yamamoto, Tsuneyuki ; Haraguchi-Kitakamae, Mai ; Ishizu, Hotaka ; Shimizu, Tomohiro ; Saito, Hitoshi ; Sakai, Sadaoki ; Yogo, Kenji ; Matsumoto, Yoshihiro ; Amizuka, Norio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c381t-a53bb9bb5425a5f8ca5f88e0f80973085af1e23bdcbe246e95c6c0d7b6bdfc853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adaptor Proteins, Signal Transducing - metabolism</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Bone and Bones - drug effects</topic><topic>Bone and Bones - metabolism</topic><topic>Bone Morphogenetic Proteins - metabolism</topic><topic>Bone Remodeling - drug effects</topic><topic>Bones</topic><topic>Epiphyses - drug effects</topic><topic>Epiphyses - metabolism</topic><topic>Ethylenediaminetetraacetic acid</topic><topic>Female</topic><topic>Genetic Markers</topic><topic>Instrument industry</topic><topic>Osteoclasts - drug effects</topic><topic>Osteoclasts - metabolism</topic><topic>Osteogenesis - drug effects</topic><topic>Osteoporosis</topic><topic>Ovariectomy</topic><topic>Pharmaceutical industry</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Tetracycline</topic><topic>Tetracyclines</topic><topic>Vitamin D - analogs & derivatives</topic><topic>Vitamin D - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hasegawa, Tomoka</creatorcontrib><creatorcontrib>Yamamoto, Tomomaya</creatorcontrib><creatorcontrib>Hongo, Hiromi</creatorcontrib><creatorcontrib>Yamamoto, Tsuneyuki</creatorcontrib><creatorcontrib>Haraguchi-Kitakamae, Mai</creatorcontrib><creatorcontrib>Ishizu, Hotaka</creatorcontrib><creatorcontrib>Shimizu, Tomohiro</creatorcontrib><creatorcontrib>Saito, Hitoshi</creatorcontrib><creatorcontrib>Sakai, Sadaoki</creatorcontrib><creatorcontrib>Yogo, Kenji</creatorcontrib><creatorcontrib>Matsumoto, Yoshihiro</creatorcontrib><creatorcontrib>Amizuka, Norio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hasegawa, Tomoka</au><au>Yamamoto, Tomomaya</au><au>Hongo, Hiromi</au><au>Yamamoto, Tsuneyuki</au><au>Haraguchi-Kitakamae, Mai</au><au>Ishizu, Hotaka</au><au>Shimizu, Tomohiro</au><au>Saito, Hitoshi</au><au>Sakai, Sadaoki</au><au>Yogo, Kenji</au><au>Matsumoto, Yoshihiro</au><au>Amizuka, Norio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eldecalcitol Induces Minimodeling-Based Bone Formation and Inhibits Sclerostin Synthesis Preferentially in the Epiphyses Rather than the Metaphyses of the Long Bones in Rats</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2024-04-01</date><risdate>2024</risdate><volume>25</volume><issue>8</issue><spage>4257</spage><pages>4257-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>This study aimed to examine minimodeling-based bone formation between the epiphyses and metaphyses of the long bones of eldecalcitol (ELD)-administered ovariectomized rats. Sixteen-week-old female rats were divided into four groups: sham-operated rats receiving vehicle (Sham group), ovariectomized (OVX) rats receiving vehicle (Vehicle group), or ELDs (30 or 90 ng/kg BW, respectively; ELD30 and ELD90 groups). ELD administration increased bone volume and trabecular thickness, reducing the number of osteoclasts in both the epiphyses and metaphyses of OVX rats. The Sham and Vehicle groups exhibited mainly remodeling-based bone formation in both regions. The epiphyses of the ELD groups showed a significantly higher frequency of minimodeling-based bone formation than remodeling-based bone formation. In contrast, the metaphyses exhibited significantly more minimodeling-based bone formation in the ELD90 group compared with the ELD30 group. However, there was no significant difference between minimodeling-based bone formation and remodeling-based bone formation in the ELD90 group. While the minimodeling-induced new bone contained few sclerostin-immunoreactive osteocytes, the underlying pre-existing bone harbored many. The percentage of sclerostin-positive osteocytes was significantly reduced in the minimodeling-induced bone in the epiphyses but not in the metaphyses of the ELD groups. Thus, it seems likely that ELD could induce minimodeling-based bone formation in the epiphyses rather than in the metaphyses, and that ELD-driven minimodeling may be associated with the inhibition of sclerostin synthesis.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38673844</pmid><doi>10.3390/ijms25084257</doi><orcidid>https://orcid.org/0000-0003-0309-6637</orcidid><orcidid>https://orcid.org/0000-0001-6760-3066</orcidid><orcidid>https://orcid.org/0000-0001-5844-9343</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2024-04, Vol.25 (8), p.4257 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_proquest_miscellaneous_3047949574 |
source | PubMed (Medline); Publicly Available Content Database (Proquest) (PQ_SDU_P3) |
subjects | Adaptor Proteins, Signal Transducing - metabolism Animals Antibodies Bone and Bones - drug effects Bone and Bones - metabolism Bone Morphogenetic Proteins - metabolism Bone Remodeling - drug effects Bones Epiphyses - drug effects Epiphyses - metabolism Ethylenediaminetetraacetic acid Female Genetic Markers Instrument industry Osteoclasts - drug effects Osteoclasts - metabolism Osteogenesis - drug effects Osteoporosis Ovariectomy Pharmaceutical industry Rats Rats, Sprague-Dawley Tetracycline Tetracyclines Vitamin D - analogs & derivatives Vitamin D - pharmacology |
title | Eldecalcitol Induces Minimodeling-Based Bone Formation and Inhibits Sclerostin Synthesis Preferentially in the Epiphyses Rather than the Metaphyses of the Long Bones in Rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T17%3A52%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eldecalcitol%20Induces%20Minimodeling-Based%20Bone%20Formation%20and%20Inhibits%20Sclerostin%20Synthesis%20Preferentially%20in%20the%20Epiphyses%20Rather%20than%20the%20Metaphyses%20of%20the%20Long%20Bones%20in%20Rats&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Hasegawa,%20Tomoka&rft.date=2024-04-01&rft.volume=25&rft.issue=8&rft.spage=4257&rft.pages=4257-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms25084257&rft_dat=%3Cgale_proqu%3EA793549854%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c381t-a53bb9bb5425a5f8ca5f88e0f80973085af1e23bdcbe246e95c6c0d7b6bdfc853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3046910364&rft_id=info:pmid/38673844&rft_galeid=A793549854&rfr_iscdi=true |